Does ETESEVIMAB Cause Infusion site extravasation? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Infusion site extravasation have been filed in association with ETESEVIMAB. This represents 1.2% of all adverse event reports for ETESEVIMAB.
14
Reports of Infusion site extravasation with ETESEVIMAB
1.2%
of all ETESEVIMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Infusion site extravasation From ETESEVIMAB?
Of the 14 reports, 1 (7.1%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETESEVIMAB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ETESEVIMAB Cause?
Infusion related reaction (290)
Dyspnoea (214)
Flushing (142)
Covid-19 (122)
Chest discomfort (117)
Nausea (88)
Back pain (85)
Covid-19 pneumonia (80)
Dizziness (74)
Chest pain (67)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which ETESEVIMAB Alternatives Have Lower Infusion site extravasation Risk?
ETESEVIMAB vs ETHACRYNIC ACID
ETESEVIMAB vs ETHAMBUTOL
ETESEVIMAB vs ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN
ETESEVIMAB vs ETHANOL
ETESEVIMAB vs ETHINYL ESTRADIOL